{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:17:10Z","timestamp":1788797830121,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijcard.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T14:28:55Z","timestamp":1466260135000},"page":"127-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study"],"prefix":"10.1016","volume":"219","author":[{"given":"Giuseppe","family":"Caminiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.06.003_bb0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Combination assessment of ranolazine in stable angina (CARISA) investigators. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0010","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"For the MARISA investigators. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (efficacy of ranolazine in chronic angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00392-007-0612-y","article-title":"Mechanism of action of the new anti-ischemia drug ranolazine","volume":"97","author":"Hasenfuss","year":"2008","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/eurheartj\/ehi495","article-title":"Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes","volume":"27","author":"Timmis","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0030","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2337\/dc09-2334","article-title":"Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome","volume":"33","author":"Chisholm","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0035","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2337\/dc14-2629","article-title":"Effect of ranolazine monotherapy on glycemic control in subjects with type 2 diabetes","volume":"38","author":"Eckel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/jpet.110.176396","article-title":"Ranolazine increases \u03b2-cell survival and improves glucose homeostasis in low-dose streptozotocin-induced diabetes in mice","volume":"337","author":"Ning","year":"2011","journal-title":"JPET"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0045","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/ATVBAHA.111.241885","article-title":"Insulin resistance and coronary heart disease in nondiabetic individuals","volume":"32","author":"Reaven","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcme.2014.07.008","article-title":"The prognosis of patients with coronary artery disease complicated by postload hyperinsulinemia","volume":"5","author":"Yamasa","year":"2014","journal-title":"IJC Metabol. Endocr."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3346\/jkms.2006.21.2.212","article-title":"The effect of insulin resistance on prognosis of non-diabetic patients who underwent percutaneous coronary intervention","volume":"21","author":"Yun","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jjcc.2013.05.006","article-title":"Insulin resistance negatively affects long-term outcome in non-diabetic patients with coronary artery disease after therapies to reduce atherosclerotic risk factors","volume":"62","author":"Kitta","year":"2013","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00275270","article-title":"Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population","volume":"19","author":"Ducimetiere","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0080","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despr\u00e9s","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.25.7.1177","article-title":"Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio heart study","volume":"25","author":"Hanley","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ijcard.2016.06.003_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc08-0854","article-title":"Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis","volume":"32","author":"Eddy","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0095","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2337\/db13-1562","article-title":"Blockade of Na1 channels in pancreatic a-cells has antidiabetic effects","volume":"63","author":"Dhalla","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2016.06.003_bb0100","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1113\/jphysiol.2013.257246","article-title":"Ranolazine recruits muscle microvasculature and enhances insulin action in rats","volume":"591","author":"Fu","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcard.2016.06.003_bb0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjcard.2004.09.025","article-title":"Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris","volume":"95","author":"Russeau","year":"2005","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316310105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T04:56:33Z","timestamp":1536641793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316310105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":21,"alternative-id":["S0167527316310105"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.003","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}